Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06734611 · ClinicalTrials.gov registry record · NA

Folic Acid Salt Study (FISFA Zambia)

A NA study, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
250
Enrollment target

NCT06734611: Recruiting NA study, sponsored by University of Alabama at Birmingham.

NCT06734611 is a NA study that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06734611, a NA study, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target

Study Summary

Question: How effective is fortified iodized salt with folic acid (FISFA) in increasing serum and red blood cell folate in non-lactating, non-pregnant women of reproductive age in the country of Zambia who do not have active food fortification with a folic acid program? Participants will: * Consume salt with folic acid instead of their regular salt for 6 months * Have a blood draw 4 times * Fill out surveys

Primary Outcome

Evaluate folate blood levels pre and post intervention

Interventions

  • DIETARY_SUPPLEMENT Fortified Iodized Salt with Folic Acid (FISFA)

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2026-04-10
Est. Completion 2028-12-31
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06734611 shows while recruiting

NCT06734611 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Fortified Iodized Salt with Folic Acid (FISFA) is the first listed.

NCT06734611 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06734611 about?

NCT06734611 is a clinical study titled "Folic Acid Salt Study (FISFA Zambia)". Question: How effective is fortified iodized salt with folic acid (FISFA) in increasing serum and red blood cell folate in non-lactating, non-pregnant women of reproductive age in the country of Zambia who do not have active food fortification with a folic acid program? Participants will: * Consum...

What is the current status of trial NCT06734611?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-04-10. Estimated completion is 2028-12-31.

What interventions are being tested in trial NCT06734611?

The interventions under investigation include: Fortified Iodized Salt with Folic Acid (FISFA) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06734611?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06734611's enrollment target sits among peer trials

250 410th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06734611, the US trial registry maintained by the National Library of Medicine. NCT06734611 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.